High-Dose Therapy with Autologous Transplantation for Aggressive Non-Hodgkin's Lymphoma: The Bologna Experience

References

• Klimo, P. and Connors, J.M. (1985) "MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma", Annals of Internal Medicine, 102, 596–601.
   Google Scholar
• Shipp, M.A., Harrington, D.P., Klatt, M.M., Jochelson, M.S., Pinkus, G.S., Marshall, J.L., et al. (1986) "Identification of major prognostic subgroups of patients with large-cell lymphoma treated with M-BACOD or m-BACOD", Annals of Internal Medicine, 104, 765–767.
   Google Scholar
• Fisher., RI., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., et al. (1993) "Comparison of a standard generation combination (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma", New England Journal of Medicine, 328, 1002 — 1006.
   Google Scholar
• Zinzani, P.I., Martelli, M., Magagnoli, M., Zaja, F., Storti, S., Pavone, E., et al. (1999) "How do patients with aggressive non-Hodgkin's lymphoma treated with third generation regimens fare in the long-term?" Haematologica, 84, 996–1001.
   Google Scholar
• Lee, A.Y., Connors, J.M., Klimo, P., O'Reilly, S.E. and Gascoyne, R.D. (1997) "Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B", Journal of Clinical Oncology, 5, 1745 — 1753.
   Google Scholar
• Cabanillas, F., Hagemeister, F.B., Bodey, G. and Freireich, E.J. (1982) "IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy", Blood, 60, 693–697.
   Google Scholar
• Cabanillas, F., Hagemeister, F.B., McLaughlin, P., Velasquez, W.S., Riggs, S., Fuller, L., et al. (1987) "Results of MIME salvage regimen for recurrent or refractory lymphoma", Journal of Clinical Oncology, 5, 407–412.
   Google Scholar
• Velasquez, W.S., Cabanillas, F., Salvador, P., McLaughlin, P., Fridrik, M., Tucker, S., et al. (1988) "Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)", Blood, 71, 117–122.
   Google Scholar
• Philip, T., Chauvin, F., Armitage, J., Bron, D., Hagenbeek, A., Biron, P., et al. (1991) "Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation", Blood, 77, 1587–1592.
   Google Scholar
• Press, O.W., Livingstone, R., Mortimer, J., Collins, M.M. and Appelbaum, F. (1991) "Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cispla-tin before bone marrow transplantation", Journal of Clinical Oncology, 9, 423–431.
   Google Scholar
• Velasquez, W.S., McLaughlin, P., Tucker, S., Hagemeister, F.B., Swan, F., Rodriguez, M.A., et al. (1994) "ESHAP-An effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study", Journal of Clinical Oncology, 12, 1169–1176.
   PubMed Web of Science ®Google Scholar
• Rodriguez, MA., Cabanillas, F.C., Velasquez, W., Hagemeister, F.B., McLaughlin, P., Swan, F., et al. (1995) "Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP", Journal of Clinical Oncology, 13, 1734 — 1741.
   Google Scholar
• Zinzani, P.I., Tani, M., Molinari, AL., Stefoni, V., Zuffa, E., Alinari, L., et al. (2002) "Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients", Haematologica, 87, 816–821.
   Google Scholar
• Philip, T. and Armitage, J. (1987) "High dose therapy and autologous bone marrow transplantation after failure on conven-tional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma", New England Journal of Medi-cine, 316, 1493 — 1498.
   Google Scholar
• Bosly, A., Coiffier, B., Gisselbrecht, C., Tilly, H., Auzanneau, G., Andrien, F., et al. (1992) "Bone marrow transplantation signifi-cantly prolongs survival after relapse in aggressive lymphoma patients treated with LNH-84 regimen", Journal of Clinical Oncology, 10, 1615 — 1623.
   Google Scholar
• Philip, T., Hartmann, O., Biron, B., Cahn, J.Y., Pein, F., Bordigoni, P., et al. (1988) "High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma", Journal of Clinical Oncol-ogy, 6, 1118–1124.
   Google Scholar
• Colombat, P., Gorin, N., Lemonnier, M., Binet, C., Laporte, J.P., Douay, L., et al. (1990) "The role of autologous bone marrow transplantation in 46 adults with non-Hodgkin's lymphoma", Journal of Clinical Oncology, 8, 630–637.
   PubMed Web of Science ®Google Scholar
• Fanin, R., Silvestri, F., Geromin, A., Cerno, M., Infanti, L., Zaja, F., et al. (1996) "Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen ( + / — radiotherapy) and autologous bone marrow transplantation", Blood, 87, 1243–1248.
   Google Scholar
• Philip, T., Guglielmi, C., Hageenbeek, A., Somers, R., Van der Lelie, H., Bron, D., et al. (1995) "Autologous bone marrow transplantation as compared with salvage chemoterapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma", New Eng-land Journal of Medicine, 333, 1540–1545.
   Google Scholar
• Shipp, M.A., Abeloff, M.D., Antman, K.H., Carroll, G., Hagen-beek, A., Loeffler, M., et al. (1999) "International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphoma: report of the Jury", Journal of Clinical Oncology, 17, 423–429.
   PubMed Web of Science ®Google Scholar
• Velasquez, W.S., Jagannath, S., Tucker, S.L., Fuller, L.M., North, LB., Redman, JR., et al. (1989) "Risk classification as the basis for clinical staging of diffuse large cell lymphoma derived from 10-year survival data", Blood, 74, 551— 557.
   Google Scholar
• Coiffier, B., Gisselbrecht, C., Vose, J.M., Tilly, H., Herbrecht, R., Bosly, A., et al. (1991) "Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy", Journal of Clinical Oncology, 9, 211 — 217.
   Google Scholar
• (1993) "The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's Lymphoma", New England Journal of Medicine, 329, 987–994.
   Google Scholar
• Santini, G., Salvagno, L., Leoni, P., Chisesi, T., De Souza, C., Sertoli, MR., et al. (1998) "VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: Results of a prospective randomized trial by the non-Hodgkin's lymphoma cooperative study group", Journal of Clinical Oncology, 16, 2796–2802.
   PubMed Web of Science ®Google Scholar
• Haioun, C., Lepage, E., Gisselbrecht, C., Salles, G., Coiffier, B., Brice, P., et al. (2000) "Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 protocol- A groupe d'etude des lym-phomes de l'adulte study", Journal of Clinical Oncology, 18, 3025 — 3030.
   Google Scholar
• Gianni, AM., Bregni, M., Siena, S., Brambilla, C., Di Nicola, M., Lombardi, F., et al. (1997) "High-dose chemotherapy and autologous bone marrow transplantation compared with MA-COP-B in aggressive B-cell lymphoma", New England Journal of Medicine, 336, 1290–1297.
   Google Scholar
• Phillips, G.L., Fay, J.W., Herzig, R.H., Lazarus, H.M., Wolff, S.N., Lin, H.S., et al. (1990) "The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and auto-logous marrow transplantation", Blood, 75, 831 —838.
   Google Scholar
• Kaiser, U., Uebelacker, I. and Havemann, K. (1999) "Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt' lymphoma and lymphoblastic lymphoma: a report on 58 patients", Leukemia & Lymphoma, 36, 101–108.
   PubMed Web of Science ®Google Scholar
• Harris, N.1., Jaffe, ES., Stein, H., Banks, P.M., Chan, J.K., Cleary, ML., et al. (1994) "A revised European-American classification of lymphoid neoplasms: A proposal from the International Lympho-ma Study Group", Blood, 84, 1361–1392.
   PubMed Web of Science ®Google Scholar
• Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W., Tubiana, M., et al. (1971) "A Report of the Committee on Hodgkin's Disease Staging Classifications", Cancer Research, 31, 1860 — 1861.
   Google Scholar
• Cheson, B.D., Horning, Si., Coiffier, B., Shipp, MA., Fisher, RI., Connors, J.M., et al. (1999) "Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group", Journal of Clinical Oncology, 17, 1244— 1252.
   Google Scholar
• Kaplan, E. and Meier, P. (1958) "Non parametric estimation from incomplete observations", Journal of the American Statistical Association, 53, 457–481.
   Web of Science ®Google Scholar
• Mantel, N. and Haenszel, W. (1959) "Statistical aspects of the analysis of data from retrospective studies of disease", Journal of the National Cancer Institute, 22, 209 — 220.
   Google Scholar
• Martelli, M., Vignetti, M., Zinzani, P.L., Gherlinzoni, F., Meloni, G., Fiacchini, M., et al. (1996) "High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front line chemotherapy: a prospective randomized Italian multicentre study", Journal of Clinical Oncol-ogy, 14, 534 — 542.
   Google Scholar
• Verdonck, L.F., van Putten, W.L., Hagenbeek, A., Schouten, H.C., Sonneveld, P., van Imhoff, G.W., et al. (1995) "Comparison of CHOP chemotherapy with autologous bone marrow transplanta-tion for slowly responding patients with aggressive non-Hodgkin's lymphoma", New England Journal of Medicine, 332, 1045 —1051.
   Google Scholar
• Martelli, M., Gherlinzoni, F., De Renzo, A., Zinzani, P.L., De Vivo, A., Cantonetti, M., et al. (2003) "Early autologous stem cell transplantation versus conventional chemotherapy as front-line therapy in high risk aggressive non-Hodgkin's lymphoma: an italian multicentric randomized trial", Journal of Clinical Oncology, 21, 1255 — 1262.
   Google Scholar
• Saba, N., Abraham, R. and Keating, A. (2000) "Overview of autologous stem cell transplantation", Critical Review in Oncology and Hematology, 36, 27–48.
   PubMed Web of Science ®Google Scholar
• Vose, J.M., Zhang, Mi., Rowlings, P.A., Lazarus, H.M., Bolwell, B.J., Freytes, C.O., et al. (2001) "Autologous Transplantation for Diffuse Aggressive Non-Hodgkin's Lymphoma in Patients Never Achieving Remission: A Report from the Autologous Blood and Marrow Transplant Registry", Journal of Clinical Oncology, 19, 406 — 413.
   Google Scholar
• Press, O.W., Eary, J.F., Gooley, T., Gopal, AK., Liu, S., Rajendran, J.G., et al. (2000) "A Phase I/II trial of iodine-131-tositumomab (anti CD-20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lympho-mas", Blood, 96, 2934–2942.
   PubMed Web of Science ®Google Scholar
• Magni, M., Di Nicola, M., Devizzi, L., Matteucci, P., Lombardi, F., Gandola, L., et al. (2000) "Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion", Blood, 96, 864–869.
   Google Scholar